These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2417206)

  • 1. Substance P receptor-mediated chemotaxis of human monocytes.
    Ruff MR; Wahl SM; Pert CB
    Peptides; 1985; 6 Suppl 2():107-11. PubMed ID: 2417206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
    Gnessi L; Ruff MR; Fraioli F; Pert CB
    Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P.
    Wiedermann CJ; Wiedermann FJ; Apperl A; Kieselbach G; Konwalinka G; Braunsteiner H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):185-90. PubMed ID: 2478893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes.
    Rot A; Henderson LE; Sowder R; Leonard EJ
    J Leukoc Biol; 1989 Feb; 45(2):114-20. PubMed ID: 2492591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis.
    Hood VC; Cruwys SC; Urban L; Kidd BL
    Regul Pept; 2000 Dec; 96(1-2):17-21. PubMed ID: 11102647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.
    Jeurissen F; Kavelaars A; Korstjens M; Broeke D; Franklin RA; Gelfand EW; Heijnen CJ
    J Immunol; 1994 Mar; 152(6):2987-94. PubMed ID: 7511635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
    Konishi S; Otsuka M
    J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist function of the neurokinin receptor antagonist, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, in monocytes.
    Djanani A; Kaneider NC; Sturn D; Wiedermann CJ
    Regul Pept; 2003 Sep; 115(2):123-9. PubMed ID: 12972327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors for substance P. III. Classification by competitive antagonists.
    Regoli D; Escher E; Drapeau G; D'Orléans-Juste P; Mizrahi J
    Eur J Pharmacol; 1984 Jan; 97(3-4):179-89. PubMed ID: 6200337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substance P receptor subtype modulating catecholamine release from adrenal chromaffin cells.
    Boksa P; Livett BG
    Brain Res; 1985 Apr; 332(1):29-38. PubMed ID: 2581649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the chemotactic migration of human fibroblasts by substance P.
    Kähler CM; Sitte BA; Reinisch N; Wiedermann CJ
    Eur J Pharmacol; 1993 Nov; 249(3):281-6. PubMed ID: 7507058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor effect of neurokinins on the rat duodenum: evidence for the involvement of substance K and substance P receptors.
    Maggi CA; Giuliani S; Manzini S; Santicioli P; Meli A
    J Pharmacol Exp Ther; 1986 Jul; 238(1):341-51. PubMed ID: 2425078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of multiple neurokinin receptors in the guinea pig ileum.
    Jacoby HI; Lopez I; Wright D; Vaught JL
    Life Sci; 1986 Nov; 39(21):1995-2003. PubMed ID: 2431245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.